Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Food and Drug Administration
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Scope and funding== As of 2021, the FDA had responsibility for overseeing $2.7 trillion in food, medical, and tobacco products.<ref name=2021faqs/> Some 54% of its budget derives from the federal government, and 46% is covered by industry user fees for FDA services.<ref name="2021faqs">{{Cite web |publisher=US Food and Drug Administration |date=November 26, 2021 |title=Fact Sheet: FDA at a Glance |url=https://www.fda.gov/economics-staff/fda-glance |access-date=February 21, 2022 |archive-date=February 24, 2022 |archive-url=https://web.archive.org/web/20220224041029/https://www.fda.gov/about-fda/fda-basics/fact-sheet-fda-glance |url-status=live }}</ref> For example, [[Pharmaceutical industry|pharmaceutical firms]] pay fees to expedite drug reviews.<ref name=2021faqs/> According to [[Forbes]], pharmaceutical firms provide 75% of the FDA's drug review budget.<ref>{{Cite news |date=September 15, 2022 |title=F.D.A.'s Drug Industry Fees Fuel Concerns Over Influence |url=https://www.nytimes.com/2022/09/15/health/fda-drug-industry-fees.html |work=NY Times}}</ref><ref>{{Cite web | vauthors = LaMattina J |date=June 28, 2018 |title=The Biopharmaceutical Industry Provides 75% Of The FDA's Drug Review Budget. Is This A Problem? |url=https://www.forbes.com/sites/johnlamattina/2018/06/28/the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-review-budget-is-this-a-problem/ |url-status=live |archive-url=https://archive.today/20230103040036/https://www.forbes.com/sites/johnlamattina/2018/06/28/the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-review-budget-is-this-a-problem/?sh=717a057449ec |archive-date=January 3, 2023 |access-date=January 3, 2023 |website=[[Forbes]] |language=en}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)